Tech Mahindra's AI Fight Against COVID-19
Tech Mahindra's Makers Lab has initiated a collaborative research project with Dr. Rahul Kumar to combat COVID-19. The team is employing Artificial Intelligence and molecular docking studies to identify potential inhibitors against the virus's main protease.
The research, conducted on 19 FDA-approved ligands and anti-viral drugs, aims to prevent the virus's entry into human host cells. Tech Mahindra's team is using AI to evaluate multiple scenarios and narrow down the search for an effective treatment. This computational analysis is the first step in their quest to find a cure for COVID-19. The project is a result of Tech Mahindra's collaboration with bio-scientists and research labs, demonstrating their commitment to drug research and testing.
Tech Mahindra's Makers Lab, in collaboration with Dr. Rahul Kumar, is actively exploring potential COVID-19 treatments using Artificial Intelligence and molecular docking. Their research, focusing on the virus's main protease, seeks to prevent viral entry into human cells and contribute to the global fight against the pandemic.
